EAACI Congress 2023
BackEfficacy and Safety of Oral Immunotherapy for Peanut Allergy in Children Aged 1 to <4 Years: Results from the POSEIDON Trial
Friday 09 Jun, 08:44 AM -
08:51 AM CEST
Hall Y 11+12
Flash Talks